It’s the at least second time this year the federal government has proposed giving exclusive rights for taxpayer-funded research to a foreign pharmaceutical giant.
By entering your email and clicking Sign Up, you're agreeing to let us send you customized marketing messages about us and our advertising partners. You are also agreeing to our Terms of Service and Privacy Policy.
